Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Document Type
Journal Article
Publication Date
9-1-2018
Journal
Anticancer research
Volume
38
Issue
9
Inclusive Pages
4969-4975
DOI
10.21873/anticanres.12815
Keywords
Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Resistance, Neoplasm; Humans; Lactams, Macrocyclic; Lung Neoplasms; Mutation; Organophosphorus Compounds; Piperidines; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Small Molecule Libraries
APA Citation
Millett, R., Elkon, J., & Tabbara, I. (2018). Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.. Anticancer research, 38 (9). http://dx.doi.org/10.21873/anticanres.12815
Peer Reviewed
1
